"10.1371_journal.pone.0064219","plos one","2013-05-14T00:00:00Z","Charline Bacchus; Antoine Cheret; Véronique Avettand-Fenoël; Georges Nembot; Adeline Mélard; Catherine Blanc; Caroline Lascoux-Combe; Laurence Slama; Thierry Allegre; Clotilde Allavena; Yazdan Yazdanpanah; Claudine Duvivier; Christine Katlama; Cécile Goujard; Bao Chau Phung Seksik; Anne Leplatois; Jean-Michel Molina; Laurence Meyer; Brigitte Autran; Christine Rouzioux; for the OPTIPRIM ANRS 147 study group","Pierre-and-Marie-Curie University Paris 06, Laboratory Immunity and Infection UMR_S 945, F-75013, Paris, France; Institut National de la Santé et de la Recherche Médicale, Laboratory Immunity and Infection UMR_S 945, F-75013, Paris, France; Paris-Descartes University, Sorbonne Paris-Cité, EA 3620, Virology Laboratory, Necker Enfants-Malades Hospital, Paris, France; Infectious Diseases Department, Gustave Dron Hospital, Tourcoing, France; Epidemiology and Public Health Department, Inserm U1018, Le Kremlin-Bicêtre Hospital, Paris, France; CyPS Flow Cytometry Platform, Pierre & Marie Curie University, Pitié-Salpêtrière Hospital, Paris, France; Infectious Diseases Department, Assistance Publique - Hôpitaux de Paris, Saint-Louis Hospital, Paris, France; Infectious Diseases Department, Assistance Publique - Hôpitaux de Paris, Tenon Hospital, Paris, France; Department of Hematology, Aix-en-Provence Hospital, Aix-en-Provence, France; Infectious Diseases Department, Hôtel-Dieu Hospital, Nantes, France; Pasteur Institute, Medical Center, Necker-Pasteur Infectious Diseases Center, Paris, France; Infectious Diseases Department, Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France; Internal Medicine and Infectious Diseases Department, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre Hospital, Paris, France; Infectious Diseases Department, Assistance Publique - Hôpitaux de Paris, Bichat Hospital, Paris, France; Infectious Diseases Department, L’Archet Hospital, Nice, France; Sorbonne Paris-Cité University, Institut National de la Santé et de la Recherche Médicale U941, Infectious Diseases Unit, Saint-Louis Hospital, Paris, France","Conceived and designed the experiments: C. Bacchus AC BA CR VAF GN CLC LS TA CA YY CD CK CG BCPS AL JMM LM. Performed the experiments: C. Bacchus AC AM C. Blanc. Analyzed the data: C. Bacchus AC VAF BA CR GN LM. Contributed reagents/materials/analysis tools: CLC LS TA CA YY CD CK CG BCPS AL JMM. Wrote the paper: C. Bacchus AC BA VAF CR.","The OPTIPRIM Agence Nationale de Recherche sur le Sida 147 study had received funding from Merck Sharp & Dohme, Jansen, ViiV Healthcare and Gilead. These companies contributed to the OPTIPRIM sub-studies. This commercial source of funding did not alter the authors’ scientific guidance and production of results, nor the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Charline Bacchus","CB",21,TRUE,1,1,1,1,TRUE,TRUE,TRUE,5,"3;4;5;18;19",TRUE
